Has this latest inflation print greenlit an ASX Santa Rally?
In this episode, IML's Simon Conn and Firetrail's Eleanor Swanson turn their attention to the short and long-term small-cap outlook.
The weight loss drug shaping-up as a gamechanger
The world is awash with news that a drug designed to treat type 2 diabetes has also been approved to help achieve weight loss. Glucagon-like peptide 1 — or GLP-1 — is...
Buy Hold Sell: 5 stocks for your naughty list in 2024
In this episode, Simon Conn from IML and Eleanor Swanson from Firetrail run the ruler over the 'naughtiest' stocks from 2023.
The CEO who kicked the incumbents to the curb (and delivered investors a +4000% return in the process)
In this episode of Success and More Interesting Stuff, HUB24's Andrew Alcock takes you through his inspirational journey.
Harvesting absolute returns via merger arbitrage | Luke Cummings
In today’s ROCast Murdoch speaks with Luke Cummings the Co-Founder, CIO & MD of Harvest Lane Asset Management about Merger Arbitrage.
Buy Hold Sell: 5 low P/E stocks with top management teams
Sometimes, you don't have to pay up for stocks with stellar leaders - but it takes a keen eye to identify them.
How to generate high alpha without high concentration | Dr David Allen
Murdoch speaks with Dr David Allen, Plato Investment Managements Head of Long/Short Strategies & PM of the Plato Global Alpha Fund.
How Benjamin Graham would invest on the ASX
In this episode, Forager's Steve Johnson and Tyndall's Jason Kim channel the father of value investing, Benjamin Graham.
Buy Hold Sell: 3 stocks on the rise (and 2 beaten-down darlings)
In this episode, Forager's Steve Johnson and Tyndall's Jason Kim analyse five stocks with both positive and negative momentum behind them.
Where to for global growth, tech & life sciences? | Michael Frazis
Murdoch speaks with Michael Frazis the MD & PM of Frazis Capital Partners about AI, Tech, Life Sciences & his new A.I. risk management tool.
1-20 of 685